Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.
Status:
Not yet recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
This study will compare stress, changes in oxygenation and oxidative damage in preterm
infants with respiratory distress syndrome (RDS) randomized to receive or not remifentanil as
an analgesic drug during the administration of porcine surfactant (poractant alfa, Curosurf®)
through the traditional (INSURE) or the less invasive (LISA) method.
Phase:
Phase 4
Details
Lead Sponsor:
Virgilio Paolo Carnielli
Collaborators:
Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona Istituto di Ricerca Pediatrica Città della Speranza